• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

丙型肝炎病毒感染慢性期丙型肝炎病毒多聚蛋白与核抗体和平滑肌抗体抗原靶点之间的分子模拟。

Mimicry between the hepatitis C virus polyprotein and antigenic targets of nuclear and smooth muscle antibodies in chronic hepatitis C virus infection.

作者信息

Gregorio G V, Choudhuri K, Ma Y, Pensati P, Iorio R, Grant P, Garson J, Bogdanos D P, Vegnente A, Mieli-Vergani G, Vergani D

机构信息

Institute of Liver Studies and Department of Child Health, King's College Hospital, GKT Medical School, London, UK.

出版信息

Clin Exp Immunol. 2003 Sep;133(3):404-13. doi: 10.1046/j.1365-2249.2003.02229.x.

DOI:10.1046/j.1365-2249.2003.02229.x
PMID:12930368
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1808793/
Abstract

Autoantibodies to smooth muscle (SMA) and nuclear components (ANA) arise in the natural course of chronic infection with hepatitis C virus. In view of the growing evidence for 'molecular mimicry' as a mechanism of autoimmunity we investigated whether cross-reactive immune reactions between host smooth muscle/nuclear components and HCV antigens may contribute to the formation of SMA and ANA in chronic HCV infection. Computer-assisted protein database search methods were used to identify three smooth muscle (smoothelin698-717, myosin1035-1054, vimentin69-88) and three nuclear (matrin722-741, histone H2A11-30, replication protein A133-152) host antigens with the highest local sequence similarity to the HCV polyprotein and 20-mer peptides corresponding to these regions were constructed. Sera from 51 children with chronic HCV infection [median age: 8 (2-16); 27 boys], 26 SMA positive and five ANA positive, were tested for reactivity to the synthesized HCV peptides and their human homologues by enzyme linked immunosorbent assay (ELISA). Sera from patients with HBV infection and chronic liver disease of different aetiologies were used as controls. 'Double reactivity' to HCV peptides and smooth muscle/nuclear homologues was associated strongly with HCV infection (P < 0.001 for both). Humoral cross-reactivity was established as the basis for double recognition by competition ELISA. Double-reactivity to smooth muscle and HCV peptide antigens correlated with SMA positivity by indirect immunofluouresence (P = 0.05). Of 15 patients double-reactive to myosin1035-1054 and its HCV homologue, 13 recognized whole myosin by immunoblot. These results suggest that ANA and SMA in chronic HCV infection may arise, at least in part, as a consequence of cross-reactive immune responses to HCV and host smooth muscle/nuclear antigens.

摘要

抗平滑肌(SMA)和核成分(ANA)自身抗体在丙型肝炎病毒慢性感染的自然病程中出现。鉴于“分子模拟”作为自身免疫机制的证据越来越多,我们研究了宿主平滑肌/核成分与HCV抗原之间的交叉反应性免疫反应是否可能导致慢性HCV感染中SMA和ANA的形成。使用计算机辅助蛋白质数据库搜索方法来鉴定与HCV多聚蛋白具有最高局部序列相似性的三种平滑肌(平滑肌蛋白698 - 717、肌球蛋白1035 - 1054、波形蛋白69 - 88)和三种核(核基质蛋白722 - 741、组蛋白H2A 11 - 30、复制蛋白A 133 - 152)宿主抗原,并构建了对应于这些区域的20肽。通过酶联免疫吸附测定(ELISA)检测了51例慢性HCV感染儿童[中位年龄:8岁(2 - 16岁);27名男孩]的血清,其中26例SMA阳性,5例ANA阳性,以检测其对合成的HCV肽及其人类同源物的反应性。来自HBV感染患者和不同病因的慢性肝病患者的血清用作对照。对HCV肽和平滑肌/核同源物的“双重反应性”与HCV感染密切相关(两者P均<0.001)。通过竞争ELISA确定体液交叉反应性是双重识别的基础。对平滑肌和HCV肽抗原的双重反应性与间接免疫荧光法检测的SMA阳性相关(P = 0.05)。在15例对肌球蛋白1035 - 1054及其HCV同源物具有双重反应性的患者中,13例通过免疫印迹法识别完整的肌球蛋白。这些结果表明,慢性HCV感染中的ANA和SMA可能至少部分是由于对HCV和宿主平滑肌/核抗原的交叉反应性免疫反应所致。

相似文献

1
Mimicry between the hepatitis C virus polyprotein and antigenic targets of nuclear and smooth muscle antibodies in chronic hepatitis C virus infection.丙型肝炎病毒感染慢性期丙型肝炎病毒多聚蛋白与核抗体和平滑肌抗体抗原靶点之间的分子模拟。
Clin Exp Immunol. 2003 Sep;133(3):404-13. doi: 10.1046/j.1365-2249.2003.02229.x.
2
Mimicry between the hepatitis B virus DNA polymerase and the antigenic targets of nuclear and smooth muscle antibodies in chronic hepatitis B virus infection.慢性乙型肝炎病毒感染中乙型肝炎病毒DNA聚合酶与核抗体和平滑肌抗体抗原靶点之间的分子模拟
J Immunol. 1999 Feb 1;162(3):1802-10.
3
Autoantibody prevalence in children with liver disease due to chronic hepatitis C virus (HCV) infection.慢性丙型肝炎病毒(HCV)感染所致肝病患儿的自身抗体患病率。
Clin Exp Immunol. 1998 Jun;112(3):471-6. doi: 10.1046/j.1365-2249.1998.00574.x.
4
A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.慢性丙型肝炎患者与自身免疫性肝炎患者自身抗体患病率的比较:干扰素在自身免疫性疾病发生中的作用。
Hepatogastroenterology. 1997 Mar-Apr;44(14):417-25.
5
Clinical significance of serum auto-antibodies in Chinese patients with chronic hepatitis C: negative role of serum viral titre and genotype.中国慢性丙型肝炎患者血清自身抗体的临床意义:血清病毒滴度和基因型的负面作用
J Gastroenterol Hepatol. 1998 May;13(5):475-9. doi: 10.1111/j.1440-1746.1998.tb00671.x.
6
Anti-ENA antibody profile in hepatitis C patients undergoing hemodialysis.接受血液透析的丙型肝炎患者的抗可提取核抗原抗体谱
Saudi J Kidney Dis Transpl. 2011 Jul;22(4):682-8.
7
Cytochrome P4502D6(193-212): a new immunodominant epitope and target of virus/self cross-reactivity in liver kidney microsomal autoantibody type 1-positive liver disease.细胞色素P4502D6(193 - 212):1型肝肾微粒体自身抗体阳性肝病中一个新的免疫显性表位及病毒/自身交叉反应的靶点
J Immunol. 2003 Feb 1;170(3):1481-9. doi: 10.4049/jimmunol.170.3.1481.
8
Expression of Hepatitis C Virus Core and E2 antigenic recombinant proteins and their use for development of diagnostic assays.丙型肝炎病毒核心抗原和E2抗原重组蛋白的表达及其在诊断检测方法开发中的应用。
Int J Infect Dis. 2015 May;34:84-9. doi: 10.1016/j.ijid.2015.03.010. Epub 2015 Mar 18.
9
Molecular mimicry of human cytochrome P450 by hepatitis C virus at the level of cytotoxic T cell recognition.丙型肝炎病毒在细胞毒性T细胞识别水平上对人细胞色素P450的分子模拟。
J Exp Med. 1999 Jul 19;190(2):169-76. doi: 10.1084/jem.190.2.169.
10
Clinical impact of non-organ-specific autoantibodies on the response to combined antiviral treatment in patients with hepatitis C.非器官特异性自身抗体对丙型肝炎患者联合抗病毒治疗反应的临床影响。
Clin Infect Dis. 2005 Feb 15;40(4):501-7. doi: 10.1086/427285. Epub 2005 Jan 21.

引用本文的文献

1
Hepatitis C Virus and Molecular Mimicry.丙型肝炎病毒与分子模拟
Pathogens. 2024 Jun 22;13(7):527. doi: 10.3390/pathogens13070527.
2
Unraveling the intricate dance of the Mediterranean diet and gut microbiota in autoimmune resilience.解析地中海饮食与肠道微生物群在自身免疫恢复力中的复杂关联。
Front Nutr. 2024 May 16;11:1383040. doi: 10.3389/fnut.2024.1383040. eCollection 2024.
3
Impact of Antigen Presentation Mechanisms on Immune Response in Autoimmune Hepatitis.抗原呈递机制对自身免疫性肝炎免疫反应的影响。
Front Immunol. 2022 Jan 18;12:814155. doi: 10.3389/fimmu.2021.814155. eCollection 2021.
4
Pathogenesis of Autoimmune Hepatitis-Cellular and Molecular Mechanisms.自身免疫性肝炎的发病机制-细胞和分子机制。
Int J Mol Sci. 2021 Dec 17;22(24):13578. doi: 10.3390/ijms222413578.
5
Negative conversion of autoantibody profile in chronic hepatitis B: A case report.慢性乙型肝炎自身抗体谱的血清学转阴:一例报告
World J Clin Cases. 2021 Feb 16;9(5):1196-1203. doi: 10.12998/wjcc.v9.i5.1196.
6
Anti-Ro60 Seropositivity Determines Anti-Ro52 Epitope Mapping in Patients With Systemic Sclerosis.抗 Ro60 阳性决定系统性硬化症患者抗 Ro52 表位图谱。
Front Immunol. 2018 Dec 7;9:2835. doi: 10.3389/fimmu.2018.02835. eCollection 2018.
7
Pathogens and autoimmune hepatitis.病原体与自身免疫性肝炎。
Clin Exp Immunol. 2019 Jan;195(1):35-51. doi: 10.1111/cei.13203. Epub 2018 Oct 7.
8
Autoantibodies in chronic hepatitis C virus infection: impact on clinical outcomes and extrahepatic manifestations.慢性丙型肝炎病毒感染中的自身抗体:对临床结局和肝外表现的影响。
BMJ Open Gastroenterol. 2018 May 5;5(1):e000203. doi: 10.1136/bmjgast-2018-000203. eCollection 2018.
9
Autoimmune reactions in the course of the hepatitis C virus (HCV) infection.丙型肝炎病毒(HCV)感染过程中的自身免疫反应。
Clin Exp Hepatol. 2015 Jun;1(2):39-43. doi: 10.5114/ceh.2015.51804. Epub 2015 Jun 2.
10
The Presence of Autoantibodies to Cytoplasmic Rod and Ring Particles in the Serum of Patients with Chronic Hepatitis C Virus Infection.慢性丙型肝炎病毒感染患者血清中针对细胞质杆状和环状颗粒自身抗体的存在情况。
Hepat Mon. 2016 Dec 11;16(12):e42388. doi: 10.5812/hepatmon.42388. eCollection 2016 Dec.

本文引用的文献

1
Autoimmune hepatitis/sclerosing cholangitis overlap syndrome in childhood: a 16-year prospective study.儿童自身免疫性肝炎/硬化性胆管炎重叠综合征:一项为期16年的前瞻性研究。
Hepatology. 2001 Mar;33(3):544-53. doi: 10.1053/jhep.2001.22131.
2
Inhibitor binding induces active site stabilization of the HCV NS3 protein serine protease domain.抑制剂结合可诱导丙型肝炎病毒NS3蛋白丝氨酸蛋白酶结构域的活性位点稳定。
EMBO J. 2000 Mar 15;19(6):1195-206. doi: 10.1093/emboj/19.6.1195.
3
International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis.国际自身免疫性肝炎小组报告:自身免疫性肝炎诊断标准综述
J Hepatol. 1999 Nov;31(5):929-38. doi: 10.1016/s0168-8278(99)80297-9.
4
Prevalence of non-organ-specific autoantibodies and chronic liver disease in the general population: a nested case-control study of the Dionysos cohort.普通人群中非器官特异性自身抗体与慢性肝病的患病率:狄俄尼索斯队列的巢式病例对照研究
Gut. 1999 Sep;45(3):435-41. doi: 10.1136/gut.45.3.435.
5
Molecular mimicry of human cytochrome P450 by hepatitis C virus at the level of cytotoxic T cell recognition.丙型肝炎病毒在细胞毒性T细胞识别水平上对人细胞色素P450的分子模拟。
J Exp Med. 1999 Jul 19;190(2):169-76. doi: 10.1084/jem.190.2.169.
6
Crossreactive recognition of viral, self, and bacterial peptide ligands by human class I-restricted cytotoxic T lymphocyte clonotypes: implications for molecular mimicry in autoimmune disease.人类I类限制性细胞毒性T淋巴细胞克隆型对病毒、自身和细菌肽配体的交叉反应性识别:对自身免疫性疾病中分子模拟的影响。
Proc Natl Acad Sci U S A. 1999 Mar 2;96(5):2279-84. doi: 10.1073/pnas.96.5.2279.
7
Mimicry between the hepatitis B virus DNA polymerase and the antigenic targets of nuclear and smooth muscle antibodies in chronic hepatitis B virus infection.慢性乙型肝炎病毒感染中乙型肝炎病毒DNA聚合酶与核抗体和平滑肌抗体抗原靶点之间的分子模拟
J Immunol. 1999 Feb 1;162(3):1802-10.
8
T cell recognition of hypervariable region-1 from hepatitis C virus envelope protein with multiple class II MHC molecules in mice and humans: preferential help for induction of antibodies to the hypervariable region.小鼠和人类中T细胞对丙型肝炎病毒包膜蛋白高变区1与多种II类主要组织相容性复合体分子的识别:对诱导针对高变区抗体的优先辅助作用
J Immunol. 1999 Jan 1;162(1):568-76.
9
Immunological cross-reactivity to multiple autoantigens in patients with liver kidney microsomal type 1 autoimmune hepatitis.1型肝肾微粒体自身免疫性肝炎患者对多种自身抗原的免疫交叉反应性。
Hepatology. 1998 Nov;28(5):1177-81. doi: 10.1002/hep.510280502.
10
Molecular mimicry and immune-mediated diseases.分子模拟与免疫介导疾病
FASEB J. 1998 Oct;12(13):1255-65. doi: 10.1096/fasebj.12.13.1255.